These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18378307)

  • 1. Necrotizing leukoencephalopathy following CHOP chemotherapy.
    Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
    Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment strategy of high malignancy non-Hodgkin lymphomas].
    Pfreundschuh M; Trümper L
    Praxis (Bern 1994); 1998 Jun; 87(23):812-5. PubMed ID: 9654988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP].
    Giménez-Mesa E; Martínez-Salio A; Porta-Etessam J; Berbel García A; Cedena Romero T; Salama Bendoyan P
    An Med Interna; 2001 Nov; 18(11):591-3. PubMed ID: 11862771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids.
    Cain MS; Burton GV; Holcombe RF
    Am J Med Sci; 1998 Mar; 315(3):202-7. PubMed ID: 9519935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
    Terenghi F; Ardolino G; Nobile-Orazio E
    J Peripher Nerv Syst; 2007 Jun; 12(2):142-3. PubMed ID: 17565540
    [No Abstract]   [Full Text] [Related]  

  • 7. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
    Shabbat S; Aharoni J; Sarid L; Ben-Harush M; Kapelushnik J
    Pediatr Blood Cancer; 2009 May; 52(5):664-6. PubMed ID: 19142990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
    Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
    Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.
    Heinz R; Pawlicki M; Losonczy H; Varbiro M; Benedek S; Konopka L; Krc I; Brugiatelli M
    Haematologica; 1986; 71(6):473-9. PubMed ID: 3104156
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversibility of the effects of the chemotherapeutic regimen for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone, on the male rat reproductive system and progeny outcome.
    Delbès G; Vaisheva F; Luu T; Marcon L; Hales BF; Robaire B
    Reprod Toxicol; 2010 Jun; 29(3):332-8. PubMed ID: 20096776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
    Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized eruptive lentiginosis induced by chemotherapy.
    De D; Dogra S; Kanwar AJ; Saikia UN
    Clin Exp Dermatol; 2010 Jun; 35(4):e113-5. PubMed ID: 19874348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
    Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
    Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
    Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary uterine lymphoma: report of 2 cases and review of literature.
    Hariprasad R; Kumar L; Bhatla DM; Kukreja M; Papaiah S
    Am J Obstet Gynecol; 2006 Jul; 195(1):308-13. PubMed ID: 16813759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
    Jordheim LP; Ribrag V; Ghesquieres H; Pallardy S; Delarue R; Tilly H; Haioun C; Jardin F; Demangel D; Salles GA; Dumontet C
    Haematologica; 2015 May; 100(5):e204-6. PubMed ID: 25637052
    [No Abstract]   [Full Text] [Related]  

  • 18. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
    Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
    Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
    Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
    Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
    Chakravarti A; Leslie WT; Venugopal P
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.